Stocktoria
ICON PLC ICLR
Nasdaq · stock · Services-Commercial Physical & Biological Research · website · IPO 1998-05-15 · LEI
ICON PLC financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.3B | $8.2B | $8.1B | $7.7B | $5.5B | $2.8B | $2.8B | $2.6B | $1.8B | $1.7B |
| SG&A expense | $780.1M | $728.3M | $768.6M | $778.8M | $585.3M | $342.4M | $332.7M | $325.8M | $323.7M | $325.7M |
| Operating income | $442.8M | $1.0B | $904.7M | $795.2M | $378.5M | $391.5M | $433.4M | $373.4M | $338.3M | $311.7M |
| Interest expense | — | — | $336.7M | $229.7M | $182.4M | $13.0M | $13.3M | — | — | — |
| Income tax | $23.1M | $64.6M | $18.4M | $59.4M | $41.3M | $47.9M | $51.1M | $42.0M | $46.6M | $38.0M |
| Net income | $229.3M | $739.1M | $554.2M | $505.3M | $153.2M | $332.3M | $374.0M | $322.7M | $281.5M | $262.2M |
| EPS (diluted) | $2.90 | $8.90 | $6.70 | $6.13 | $2.25 | $6.15 | $6.79 | $5.89 | $5.13 | $4.65 |
| Operating cash flow | $1.0B | $1.3B | $1.2B | $563.3M | $829.1M | $568.0M | $412.5M | $268.6M | $383.1M | $259.2M |
| Free cash flow | $862.0M | $1.1B | $1.0B | $421.2M | $735.4M | $527.1M | $373.6M | $220.2M | $338.4M | $216.6M |
| Cash & equivalents | $647.3M | $538.8M | $378.1M | $288.8M | $752.2M | $840.3M | $520.3M | $395.9M | $282.9M | $192.5M |
| Inventory | — | — | — | — | $5.8M | $4.8M | $3.2M | $2.3M | $2.2M | $2.4M |
| Total assets | $16.3B | $16.6B | $16.9B | $17.2B | $17.4B | $3.4B | $2.9B | $2.4B | $2.1B | $1.8B |
| Total liabilities | $7.1B | $7.2B | $7.7B | $8.7B | $9.3B | $1.6B | $1.2B | $1000.0M | $955.6M | $880.7M |
| Shareholders' equity | $9.2B | $9.4B | $9.2B | $8.5B | $8.1B | $1.9B | $1.6B | $1.4B | $1.2B | $945.2M |
Growth · year-over-year · Revenue CAGR 19.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +0.8% | +1.7% | +4.1% | +41.2% | +95.9% | -0.3% | +8.1% | +47.6% | +5.5% | +5.8% |
| Net income growth | -69.0% | +33.4% | +9.7% | +229.9% | -53.9% | -11.1% | +15.9% | +14.6% | +7.4% | +9.5% |
| EPS growth | -67.4% | +32.8% | +9.3% | +172.4% | -63.4% | -9.4% | +15.3% | +14.8% | +10.3% | +17.1% |
| Free cash flow growth | -22.9% | +9.6% | +142.3% | -42.7% | +39.5% | +41.1% | +69.6% | -34.9% | +56.2% | -5.6% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.